Research Article: CD Dysregulates Monocyte Anti-Tumor Activity in Multiple Myeloma
Introduction:
Multiple myeloma (MM) is a plasma cell neoplasm in the bone marrow (BM). The global incidence of MM in was ,, an increase of .% since . , Current myeloma therapies such as proteasome inhibitors, immunomodulatory agents, monoclonal antibodies, and BM transplantation, prolong the survival and improve the prognosis of patients; however, these methods are rarely curative and disease relapse is common. Therefore, new treatments are necessary to improve patient outcomes.
Read more